Welcome to LookChem.com Sign In|Join Free

CAS

  • or

258870-13-2

258870-13-2

Post Buying Request

258870-13-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

258870-13-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 258870-13-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,5,8,8,7 and 0 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 258870-13:
(8*2)+(7*5)+(6*8)+(5*8)+(4*7)+(3*0)+(2*1)+(1*3)=172
172 % 10 = 2
So 258870-13-2 is a valid CAS Registry Number.

258870-13-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name (2R,3S)-N<sup>4</sup>-Hydroxy-2-isobutyl-N<sup>1</sup>-[2-oxo-1-(3-phenoxybenzyl)-3-azepanyl]-3-propylsuccinamide

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:258870-13-2 SDS

258870-13-2Upstream product

258870-13-2Downstream Products

258870-13-2Relevant articles and documents

Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging

-

, (2008/06/13)

This invention relates to a novel method of screening for inhibitors of beta-amyloid production, and thereby identifying such inhibitors as therapeutics for neurological and other disorders involving APP processing and beta-amyloid production. This invent

Use of small molecule radioligands to discover inhibitors of amyloid-beta peptide production and for diagnostic imaging

-

, (2008/06/13)

This invention relates to a method of using radiolabelled and/or radiopharmaceutical small molecule inhibitors of beta-amyloid peptide production for the diagnosis of neurological and other disorders involving APP processing and beta-amyloid production. Furthermore, radiolabelled small molecule inhibitors identified by the methods of the present invention would be useful in the diagnosis of neurological disorders, such as Alzheimer's disease, which involve elevated levels of Aβ peptides.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 258870-13-2